Literature DB >> 20015273

Low numbers of CD8+ T lymphocytes in hereditary haemochromatosis are explained by a decrease of the most mature CD8+ effector memory T cells.

M F Macedo1, G Porto, M Costa, C P Vieira, B Rocha, E Cruz.   

Abstract

Low CD8(+) T lymphocyte numbers have long been described in hereditary haemochromatosis (HH). Recently, two conserved haplotypes localized near the microsatellite D6S105 at the major histocompatibility complex (MHC) class I region were described predicting the clinical expression of HH and the CD8(+) T lymphocyte numbers. The A-A-T haplotype was associated with a severe clinical expression of HH and low CD8(+) T lymphocyte numbers, while the G-G-G haplotype was associated with a milder clinical expression of HH and high CD8(+) T lymphocyte numbers. As CD8(+) T lymphocytes are a very heterogeneous population, in this study we analysed the CD8(+) subpopulations of naive, central memory (T(CM)) and effector memory (T(EM)), and further subsets of CD8(+) T(EM) cells in 47 HH patients and 68 controls. In addition, association studies were conducted between the conserved haplotypes and the CD8(+) T cell subpopulations in HH. Variations of the numbers of naive and central memory cells with age were similar between HH patients and controls. For T(EM) cells and the T(EM) CD27(-)CD28(-) subset no effect of age was observed in HH [R(2) = 0.001, not significant (n.s.) and R(2) = 0.01, n.s., respectively] contrasting with the increasing of these subpopulations with age in controls (R(2) = 0.09, P = 0.017 and R(2) = 0.22, P = 0.0005, respectively). Interestingly, patients homozygous for the A-A-T haplotype have lower numbers of CD8(+) T(EM) cells due especially to lower numbers of T(EM) CD27(-)CD28(-) (0.206 +/- 0.119 and 0.066 +/- 0.067 x 10(6) cells/ml, respectively) than patients carrying the G-G-G haplotype (0.358 +/- 0.195 and 0.246 +/- 0.202 x 10(6) cells/ml, respectively). This may suggest an inability of HH patients to differentiate the CD8(+) T cells into the most mature phenotype.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20015273      PMCID: PMC2819502          DOI: 10.1111/j.1365-2249.2009.04066.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis.

Authors:  J N Feder; A Gnirke; W Thomas; Z Tsuchihashi; D A Ruddy; A Basava; F Dormishian; R Domingo; M C Ellis; A Fullan; L M Hinton; N L Jones; B E Kimmel; G S Kronmal; P Lauer; V K Lee; D B Loeb; F A Mapa; E McClelland; N C Meyer; G A Mintier; N Moeller; T Moore; E Morikang; C E Prass; L Quintana; S M Starnes; R C Schatzman; K J Brunke; D T Drayna; N J Risch; B R Bacon; R K Wolff
Journal:  Nat Genet       Date:  1996-08       Impact factor: 38.330

2.  Accumulation of memory T cells from childhood to old age: central and effector memory cells in CD4(+) versus effector memory and terminally differentiated memory cells in CD8(+) compartment.

Authors:  Pasquine Saule; Jacques Trauet; Virginie Dutriez; Véronique Lekeux; Jean-Paul Dessaint; Myriam Labalette
Journal:  Mech Ageing Dev       Date:  2005-12-13       Impact factor: 5.432

3.  Four functionally distinct populations of human effector-memory CD8+ T lymphocytes.

Authors:  Pedro Romero; Alfred Zippelius; Isabel Kurth; Mikaël J Pittet; Cédric Touvrey; Emanuela M Iancu; Patricia Corthesy; Estelle Devevre; Daniel E Speiser; Nathalie Rufer
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

4.  Iron metabolism; iron stores in man as measured by phlebotomy.

Authors:  D HASKINS; A R STEVENS; S FINCH; C A FINCH
Journal:  J Clin Invest       Date:  1952-06       Impact factor: 14.808

5.  Relative impact of HLA phenotype and CD4-CD8 ratios on the clinical expression of hemochromatosis.

Authors:  G Porto; C Vicente; M A Teixeira; O Martins; J M Cabeda; R Lacerda; C Goncalves; J Fraga; G Macedo; B M Silva; H Alves; B Justiça; M de Sousa
Journal:  Hepatology       Date:  1997-02       Impact factor: 17.425

6.  Decreased CD8-p56lck activity in peripheral blood T-lymphocytes from patients with hereditary haemochromatosis.

Authors:  F A Arosa; A J da Silva; I M Godinho; J C ter Steege; G Porto; C E Rudd; M de Sousa
Journal:  Scand J Immunol       Date:  1994-05       Impact factor: 3.487

7.  Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectinlike receptor G1 (KLRG1).

Authors:  David Voehringer; Marie Koschella; Hanspeter Pircher
Journal:  Blood       Date:  2002-07-12       Impact factor: 22.113

8.  A putative gene located at the MHC class I region around the D6S105 marker contributes to the setting of CD8+ T-lymphocyte numbers in humans.

Authors:  J Vieira; C S Cardoso; J Pinto; K Patil; P Brazdil; E Cruz; C Mascarenhas; R Lacerda; A Gartner; S Almeida; H Alves; G Porto
Journal:  Int J Immunogenet       Date:  2007-10       Impact factor: 1.466

9.  A study of 82 extended HLA haplotypes in HFE-C282Y homozygous hemochromatosis subjects: relationship to the genetic control of CD8+ T-lymphocyte numbers and severity of iron overload.

Authors:  Eugénia Cruz; Jorge Vieira; Susana Almeida; Rosa Lacerda; Andrea Gartner; Carla S Cardoso; Helena Alves; Graça Porto
Journal:  BMC Med Genet       Date:  2006-03-01       Impact factor: 2.103

10.  Multiparameter flow cytometric analysis of CD4 and CD8 T cell subsets in young and old people.

Authors:  Sven Koch; Anis Larbi; Evelyna Derhovanessian; Dennis Ozcelik; Elissaveta Naumova; Graham Pawelec
Journal:  Immun Ageing       Date:  2008-07-25       Impact factor: 6.400

View more
  13 in total

Review 1.  Iron and immunity: immunological consequences of iron deficiency and overload.

Authors:  Bobby J Cherayil
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2010-09-28       Impact factor: 4.291

2.  Invariant Natural Killer T Cells are Reduced in Hereditary Hemochromatosis Patients.

Authors:  M L Maia; C S Pereira; G Melo; I Pinheiro; M A Exley; G Porto; M F Macedo
Journal:  J Clin Immunol       Date:  2014-12-06       Impact factor: 8.317

Review 3.  The role of MHC class Ib-restricted T cells during infection.

Authors:  Courtney K Anderson; Laurent Brossay
Journal:  Immunogenetics       Date:  2016-07-01       Impact factor: 2.846

4.  Lymphocyte subsets in alcoholic liver disease.

Authors:  Luís Costa Matos; Paulo Batista; Nuno Monteiro; João Ribeiro; Maria A Cipriano; Pedro Henriques; Fernando Girão; Armando Carvalho
Journal:  World J Hepatol       Date:  2013-02-27

5.  Lymphocyte gene expression signatures from patients and mouse models of hereditary hemochromatosis reveal a function of HFE as a negative regulator of CD8+ T-lymphocyte activation and differentiation in vivo.

Authors:  Mónica Costa; Eugénia Cruz; Susana Oliveira; Vladimir Benes; Tomi Ivacevic; Maria João Silva; Inês Vieira; Francisco Dias; Sónia Fonseca; Marta Gonçalves; Margarida Lima; Catarina Leitão; Martina U Muckenthaler; Jorge Pinto; Graça Porto
Journal:  PLoS One       Date:  2015-04-16       Impact factor: 3.240

Review 6.  The hemochromatosis protein HFE 20 years later: An emerging role in antigen presentation and in the immune system.

Authors:  Alexandre Reuben; Jacqueline W Chung; Réjean Lapointe; Manuela M Santos
Journal:  Immun Inflamm Dis       Date:  2017-04-19

Review 7.  Iron in the Tumor Microenvironment-Connecting the Dots.

Authors:  Christa Pfeifhofer-Obermair; Piotr Tymoszuk; Verena Petzer; Günter Weiss; Manfred Nairz
Journal:  Front Oncol       Date:  2018-11-26       Impact factor: 6.244

8.  Conditional deletion of ferritin h in mice reduces B and T lymphocyte populations.

Authors:  Liviu Vanoaica; Larry Richman; Maike Jaworski; Deepak Darshan; Sanjiv A Luther; Lukas C Kühn
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

Review 9.  Human Leukocyte Antigen (HLA) and Immune Regulation: How Do Classical and Non-Classical HLA Alleles Modulate Immune Response to Human Immunodeficiency Virus and Hepatitis C Virus Infections?

Authors:  Nicole B Crux; Shokrollah Elahi
Journal:  Front Immunol       Date:  2017-07-18       Impact factor: 7.561

Review 10.  Iron Administration, Infection, and Anemia Management in CKD: Untangling the Effects of Intravenous Iron Therapy on Immunity and Infection Risk.

Authors:  Tomas Ganz; George R Aronoff; Carlo A J M Gaillard; Lawrence T Goodnough; Iain C Macdougall; Gert Mayer; Graça Porto; Wolfgang C Winkelmayer; Jay B Wish
Journal:  Kidney Med       Date:  2020-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.